首页> 外文OA文献 >Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

【2h】

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

机译：随机阶段III安慰剂对照试验Letrozole Plus口服Temsirolimus作为患有局部晚期或转移性乳腺癌的绝经后妇女的一线内分泌治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Antonio C. Wolff; Ann A. Lazar; Igor Bondarenko; August M. Garin; Stephen Brincat; Louis Chow; Yan Sun; Zora Neskovic-Konstantinovic; Rodrigo C. Guimaraes; Pierre Fumoleau; Arlene Chan; Soulef Hachemi; Andrew Strahs; Maria Cincotta; Anna Berkenblit; Mizue Krygowski; Lih Lisa Kang; Laurence Moore; Daniel F. Hayes;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer [J] . Journal of Clinical Oncology . 2013,第2期

机译：来曲唑加口服西罗莫司作为一线内分泌疗法在绝经后患有局部晚期或转移性乳腺癌的女性中进行的随机III期安慰剂对照试验
3. Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer [J] . Beverly Moy, Patrick Neven, Fabienne Lebrun, The oncologist . 2014,第4期

机译：Bosutinib与芳香酶抑制剂来曲唑的组合：绝经后妇女评估局部晚期或转移性激素受体阳性/ HER2阴性乳腺癌的一线内分泌治疗的II期试验
4. BOLERO-1: A Randomized, Phase III, Double-Blind, Placebo-Controlled Multicenter Trial of Everolimus in Combination With Trastuzumab and Paclitaxel as First-Line Therapy in Women With HER2-Positive (HER2 + ), Locally Advanced or Metastatic Breast Cancer (BC) [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla14期

机译：BOLERO-1：依维莫司联合曲妥珠单抗和紫杉醇作为一线治疗对HER2阳性（HER2 +），局部晚期或转移性乳腺癌的女性进行的随机，III期，双盲，安慰剂对照的依维莫司多中心试验公元前）
5. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
6. A time to question: A study of the information needs of postmenopausal breast cancer patients regarding endocrine therapy. [D] . TeBrake, Melissa Lynn. 2010

机译：问题时间：对绝经后乳腺癌患者有关内分泌治疗的信息需求的研究。
7. Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer [O] . Antonio C. Wolff, Ann A. Lazar, Igor Bondarenko, -1

机译：来曲唑加口服替罗罗莫司的III期安慰剂对照随机试验作为绝经后女性局部晚期或转移性乳腺癌的一线内分泌治疗
8. Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First‐Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor‐Positive/HER2‐Negative Breast Cancer [O] . Beverly Moy, Patrick Neven, Fabienne Lebrun, 2014

机译：Bosutinib与芳香酶抑制剂Letrozole：绝经后妇女的II期试验评估局部晚期或转移激素受体阳性/ HER2阴性乳腺癌的一线内分泌治疗

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

著录项

相似文献

相关主题

期刊订阅